Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.
4.
5.
6.

Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.

Martin P, Parroche P, Chatel L, Barretto C, Beck A, Trépo C, Bain C, Lone YC, Inchauspé G, Fournillier A.

J Med Virol. 2004 Nov;74(3):397-405.

PMID:
15368525
7.

Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide.

Lasarte JJ, Corrales FJ, Casares N, López-Díaz de Cerio A, Qian C, Xie X, Borrás-Cuesta F, Prieto J.

J Immunol. 1999 May 1;162(9):5270-7.

8.

Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model.

Wedemeyer H, Gagneten S, Davis A, Bartenschlager R, Feinstone S, Rehermann B.

Gastroenterology. 2001 Nov;121(5):1158-66.

PMID:
11677208
9.

Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.

Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.

Virus Res. 2006 Mar;116(1-2):11-20. Epub 2005 Oct 7.

PMID:
16214252
10.

Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.

Himoudi N, Abraham JD, Fournillier A, Lone YC, Joubert A, Op De Beeck A, Freida D, Lemonnier F, Kieny MP, Inchauspé G.

J Virol. 2002 Dec;76(24):12735-46.

11.
12.
13.

Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine.

Wu Y, Wan T, Zhou X, Wang B, Yang F, Li N, Chen G, Dai S, Liu S, Zhang M, Cao X.

Cancer Res. 2005 Jun 1;65(11):4947-54.

14.

Coupling to the surface of liposomes alters the immunogenicity of hepatitis C virus-derived peptides and confers sterile immunity.

Takagi A, Kobayashi N, Taneichi M, Uchida T, Akatsuka T.

Biochem Biophys Res Commun. 2013 Jan 4;430(1):183-9. doi: 10.1016/j.bbrc.2012.11.028. Epub 2012 Nov 15.

PMID:
23159619
15.

Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response.

Parajuli P, Pisarev V, Sublet J, Steffel A, Varney M, Singh R, LaFace D, Talmadge JE.

Cancer Res. 2001 Nov 15;61(22):8227-34.

16.

Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.

Gupta S, Boppana R, Mishra GC, Saha B, Mitra D.

Immunology. 2008 Aug;124(4):553-61. doi: 10.1111/j.1365-2567.2008.02809.x. Epub 2008 Feb 20.

17.

DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens.

Rice J, Dunn S, Piper K, Buchan SL, Moss PA, Stevenson FK.

Cancer Res. 2006 May 15;66(10):5436-42.

18.

Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.

Amacker M, Engler O, Kammer AR, Vadrucci S, Oberholzer D, Cerny A, Zurbriggen R.

Int Immunol. 2005 Jun;17(6):695-704. Epub 2005 Apr 20.

PMID:
15843436
19.

Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine.

Memarnejadian A, Roohvand F.

Cell Immunol. 2010;261(2):93-8. doi: 10.1016/j.cellimm.2009.11.005. Epub 2010 Jan 6.

20.

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.

Zabaleta A, Arribillaga L, Llopiz D, Dotor J, Lasarte JJ, Prieto J, Borrás-Cuesta F, Esteban JI, Quer J, Vayreda F, Sarobe P.

Antiviral Res. 2007 Apr;74(1):25-35. Epub 2007 Jan 22.

Supplemental Content

Support Center